Clinical trial
B2-Adrenergic Receptor Polymorphisms: Implications For The Treatment Of Status Asthmaticus In Children
NCT00279786 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- B2-Adrenergic Receptor Polymorphisms: Implications For The Treatment Of Status Asthmaticus In Children
- Lead sponsor
- Connecticut Children's Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- January 31, 2009
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.